Prognostic factors and relative risk for survival in N1-3 oral squamous cell carcinoma: A multivariate analysis using Cox's hazard model

British Journal of Oral and Maxillofacial Surgery

Volumn 37, Issue 6, 1999, Pages 433-437

  Noguchi, M ^a   Kido, Y ^a   Kubota, H ^a   Kinjo, H ^a   Kohama, G ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; METHOTREXATE; PEPLEOMYCIN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MOUTH CARCINOMA; MULTIVARIATE ANALYSIS; PREDICTION; PROGNOSIS; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; STATISTICAL MODEL;

EID: 0033388352     PISSN: 02664356     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjom.1999.0146     Document Type: Article

References (25)

1. Dreyfuss AI, Clark JR. Analysis of prognostic factors in squamous cell carcinomas of the head and neck. Hematol Oncol Clin North Am 1991; 5: 701-712.
2. Million RR, Cassisi NJ. Management of head and neck cancer, 2nd edn. Philadelphia: JB Lippincott, 1994:75.
3. Spaulding MB, Vasquez J, Khan A et al. A nontoxic adjuvant treatment for advanced head and neck cancer. Arch Otolaryngol 1983; 109: 789-791.
4. Cognetti F, Pinnaro P, Ruggeri EM et al. Prognostic factors for chemotherapy response and survival using combination chemotherapy as initial treatment of advanced head and neck squamous cell cancer. J Clin Oncol 1989; 7: 829-837.
5. Tytor M, Franzen G, Olofsson J. DNA ploidy in oral cavity carcinomas, with special reference to prognosis. Head Neck 1989; 11: 257-263.
6. Howaldt HP, Frenz M, Pitz H. Proposal for a modified T-classification for oral cancer. J Craniomaxillofac Surg 1992; 21: 96-101.
7. Bundgaard T, Bentzen S, Widt J, Sφprensen FB, Sφpgaard H, Nielsen JE. Histopathologic, stereologic, epidemiologic, and clinical parameters in the prognostic evaluation of squamous cell carcinoma of the oral cavity. Head Neck 1996; 18: 142-152.
8. Moor C, Flynn MB, Greenberg RA. Evaluation of size in prognosis of oral cancer. Cancer 1986; 58: 158-162.
9. Leemans CR, Tiwari R, Nauta JJP, van der Waal I, Snow GB. Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor. Cancer 1994; 73: 187-190.
10. Kohama G. Surgical management of oral cancer with special reference to clinical staging and histological grading. Oral Oncol 1991; 1: 77-79.
11. Yamamoto E, Kohama G, Sunakawa H, Iwai M, Hiratsuka H. Mode of invasion, bleomycin sensitivity, and clinical course in squamous cell carcinoma of the oral cavity. Cancer 1983; 51: 2175-23180.
12. Bocca E, Difnataro O, Oldini C, Cappa C. Functional neck dissection: an evaluation and review of 843 cases. Laryngoscope 1984; 94: 942-945.
13. Bryne M, Koppang HS, Lilleng R, Kjaerheim A. Malignancy grading of the deep invasive margins of oral squamous cell carcinomas has high prognostic value. J Pathol 1992; 166: 375-387.
14. Gallo O, Boddi V, Bottai GV, Franchi A, Storchi OF. Prognostic significance of clinically false positive cervical lymph nodes in patients with laryngeal carcinoma. Cancer 1995; 75: 1077-1083.
15. Cerezo L, Millan I, Torre A, Aragon G, Otero J. Prognostic factors for survival and tumor control in cervical lymph node metastases from head and neck cancer A multivariate study of 492 cases. Cancer 1992; 69: 1224-1234.
16. Mamelle G, Pampurik J, Luboinski B et al. Lymph node prognostic factors in head and neck squamous cell carcinomas. Am J Surg 1994; 168: 494-498.
17. Leemans CR, Tiwari R, Nauta JJP, van der Waal, Snow GB. Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma. Cancer 1993; 71: 452-456.
18. Snow GB, Annyas EA, van Slooten EA, Bartelink H, Hart AAM. Prognostic factors of neck node metastasis. Clin Otolaryngol 1982; 7: 185-192.
19. Brasilino de Carcalho M. Quantitative analysis of the extent of extra capsular invasion and its prognostic significance: a prospective study of 170 cases of carcinoma of the larynx and hypopharynx. Head Neck 1998; 20: 16-21.
20. Carter RL, Barr LC, O'Brien CJ, Soo KC, Shaw HJ. Transcapsular spread of metastatic squamous cell carcinoma from cervical lymph nodes. Am J Surg 1985; 150: 495-499.
21. Esclamado R, Carroll WR. Extracapsular spread and the perineural extension of squamous cell cancer in the cervical plexus. Arch Otolaryngol Head Neck Surg 1992; 118: 1157-1158.
22. Huang DT, Johnson CR, Schmidt-Ullrich R, Grimes M. Postoperative radiotherapy in head and neck carcinoma with extracapsular lymph node extension and/or positive resection margins: a comparative study. Int J Radiation Oncology Biol Phys 1992; 23: 737-742.
23. Johnson JT, Wanger RL, Myers EN. A long-term assessment of adjuvant chemotherapy on outcome of patients with extracapsular spread of cervical metastases from squamous carcinoma of the head and neck. Cancer 1996; 77: 181-185.
24. Brown DC, Purushotham AD, Brinie GD, George WD. Detection of intraoperative turn or cell dissemination in patients with breast cancer by use of reverse transcription and polymerase chain reaction. Surgery 1995; 117: 96-101.
25. Mori M, Mimori K, Ueo H et al. Molecular detection of circulating solid carcinoma cells in the peripheral blood: the concept of early systemic disease. Int J Cancer 1996; 68: 739-743.